GlassScriptPhysician profile
Shamlal Tekwani
NPI 1962472480
$1,783.38
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $45.08 · 2021: $145 · 2022: $197 · 2023: $984 · 2024: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,089 · Education: $10.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,088.94 |
| Education | $10.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $305.29 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $287.64 | 2022-2024 | Miebo, Xiidra |
| Mallinckrodt Hospital Products INC. | $245.57 | 2023 | Acthar |
| Alcon Vision LLC | $206.01 | 2022-2024 | Rocklatan, Simbrinza, Rhopressa |
| Dompe US, INC. | $121.80 | 2023 | Oxervate |
| Genentech USA, INC. | $109.85 | 2023 | Vabysmo |
| Sun Pharmaceutical Industries INC. | $108.49 | 2022-2024 | Cequa, Xelpros |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $101.74 | 2019-2021 | |
| Thea Pharma INC. | $57.92 | 2023-2024 | Iyuzeh |
| Abbvie INC. | $52.15 | 2022-2024 | |
| Alimera Sciences, INC. | $44.19 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $35.05 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $34.26 | 2019 | |
| Kala Pharmaceuticals, INC. | $23.29 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.77 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spark Therapeutics, INC. | $16.48 | 2020 | |
| Horizon Therapeutics Plc | $15.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shamlal Tekwani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.